BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3615918)

  • 41. [Madecassol in the treatment of scleroderma (preliminary study)].
    Szczepański A; Dabrowska H; Blaszczyk M
    Przegl Dermatol; 1974; 61(5):701-3. PubMed ID: 4419170
    [No Abstract]   [Full Text] [Related]  

  • 42. Calcipotriol-betamethasone ointment versus calcipotriol ointment in the treatment of psoriasis vulgaris.
    Duweb G; Alhaddar J; Elsherif B; Eljehawi N; Makhlouf H
    Drugs Exp Clin Res; 2005; 31(5-6):175-9. PubMed ID: 16425973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The percutaneous action of a heparin-allantoin-dexpanthenol combination in a specific ointment base. Thrombolytic action on the rabbit ear].
    Tauschel HD; Bonacina F; Galetti F
    Arzneimittelforschung; 1984; 34(12):1768-72. PubMed ID: 6543312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of dimexide ointment with monomycin in the treatment of corneal burns].
    Podkova VG
    Oftalmol Zh; 1976; 31(5):367-71. PubMed ID: 799269
    [No Abstract]   [Full Text] [Related]  

  • 45. [Use of a sage ointment in treating cracked lips].
    Marchenko AI; Pinchuk VN; Shvets IV
    Stomatologiia (Mosk); 1978; 57(1):86-7. PubMed ID: 272775
    [No Abstract]   [Full Text] [Related]  

  • 46. Kenacort A in the treatment of hypertrophic scars and keloids in children.
    Jaworski S
    Acta Chir Plast; 1973; 15(4):206-15. PubMed ID: 4130552
    [No Abstract]   [Full Text] [Related]  

  • 47. [The percutaneous effect of a heparin-allantoin-dexpanthenol combination in a specific ointment base. Anti-allergic, anti-inflammatory effect in the PCA test in the rat].
    Rudolph C; Tauschel HD
    Arzneimittelforschung; 1984; 34(12):1766-8. PubMed ID: 6543311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Nerve regeneration of hypertrophic scars and keloids after deep burns].
    Song Y; Cen Y; Xen XW; Liu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 36(6):797-9. PubMed ID: 16334556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Possibilities of employing the extracts from Bulbus cepae in dermopreparations].
    Gafiţanu E; Matei I; Bazgan O; Almăşan S
    Rev Med Chir Soc Med Nat Iasi; 1982; 86(2):258. PubMed ID: 25588246
    [No Abstract]   [Full Text] [Related]  

  • 50. An experience in treating five hundred and one patients with keloids.
    Inalsingh CH
    Johns Hopkins Med J; 1974 May; 134(5):284-90. PubMed ID: 4826125
    [No Abstract]   [Full Text] [Related]  

  • 51. [Dipromonium in the treatment of scleroderma patients].
    Khamaganova IV
    Vestn Dermatol Venerol; 1989; (6):67-70. PubMed ID: 2588793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The treatment of burns with a topical spray.
    Ghani AN; Omar M
    Ther Hung; 1988; 36(4):179-81. PubMed ID: 3253962
    [No Abstract]   [Full Text] [Related]  

  • 53. Dimethyl sulfoxide as a vehicle for corticosteroids. A comparison with the occlusive dressing technique.
    Groel JT
    Arch Dermatol; 1968 Feb; 97(2):110-4. PubMed ID: 5636042
    [No Abstract]   [Full Text] [Related]  

  • 54. Betadine ointment for burn care in the community hospital.
    Barr LL
    J Am Osteopath Assoc; 1977 Feb; 76(6):458-61. PubMed ID: 584234
    [No Abstract]   [Full Text] [Related]  

  • 55. Topical tacrolimus in the treatment of localized scleroderma.
    Mancuso G; Berdondini RM
    Eur J Dermatol; 2003; 13(6):590-2. PubMed ID: 14721783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cervical cutaneous expansion: treatment of post-burn keloids. Personal cases].
    Monti M; Muratori L; Grilli P; Redler A; Pasta V
    Ann Ital Chir; 1987; 59(1-6):285-92. PubMed ID: 3503615
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of localized scleroderma with systemic administration of a corticosteroid hormone].
    Yanase S; Yamazaki S; Furuya T
    Nihon Hifuka Gakkai Zasshi; 1987 Apr; 97(5):581-5. PubMed ID: 3613220
    [No Abstract]   [Full Text] [Related]  

  • 58. The Effectiveness of Topical Anti-scarring Agents and a Novel Combined Process on Cutaneous Scar Management.
    Fang QQ; Chen CY; Zhang MX; Huang CL; Wang XW; Xu JH; Wu LH; Zhang LY; Tan WQ
    Curr Pharm Des; 2017; 23(15):2268-2275. PubMed ID: 27784253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical study of a new antikeloid agent.
    Bossé JP; Papillon J; Frenette G; Dansereau J; Cadotte M; Le Lorier J
    Ann Plast Surg; 1979 Jul; 3(1):13-21. PubMed ID: 396846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Caring for perilesional skin or skin having a lesion risk].
    Segovia GT; Javares CT; Barahona M; Verdú SJ
    Rev Enferm; 2007 Oct; 30(10):43-8. PubMed ID: 18274396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.